Purchases and Sales Made in Q4 2023 in Gain Therapeutics, Inc. (GANX)
This table provides information about the institutional ownership of Gain Therapeutics, Inc. (GANX) during Q4 2023. The information is specifically focused on institutions that hold shares of Gain Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
David Einhorn
Greenlight Capital Inc | New York, Ny
|
BUY
|
- |
41.9K+ 7.66% |
$86.6K - $142K
|
588K
$1.05M
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
30.2K+ 227.73% |
$62.6K - $103K
|
43.5K
$77.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
19.5K+ 42.55% |
$40.4K - $66.4K
|
65.4K
$117K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
18.1K+ 25.76% |
$37.5K - $61.6K
|
88.4K
$158K
|
|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
11.5KNew |
$23.7K - $38.9K
|
11.5K
$20.5K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
5.72K+ 68.87% |
$11.8K - $19.4K
|
14K
$25.1K
|
|
|
Mar 01, 2024
Q4 2023
|
Creekmur Asset Management LLC
Morton, IL |
BUY
|
- |
4.44KNew |
$9.19K - $15.1K
|
4.44K
$7.95K
|
|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.02K+ 70.45% |
$4.19K - $6.87K
|
4.89K
$8.76K
|
|
|
Feb 14, 2024
Q4 2023
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
2K+ 103.25% |
$4.14K - $6.8K
|
3.94K
$7.05K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
1.5K+ 115.38% |
$3.1K - $5.1K
|
2.8K
$5.01K
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
202+ 1.61% |
$418 - $687
|
12.8K
$22.8K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 0.11% |
$8.28 - $13.6
|
3.73K
$6.67K
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-314- 1.12% |
$650 - $1.07K
|
27.6K
$49.4K
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-500- 15.15% |
$1.04K - $1.7K
|
2.8K
$5.01K
|
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-933- 5.55% |
$1.93K - $3.17K
|
15.9K
$28.4K
|
|
|
Feb 13, 2024
Q4 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-4.1K- 8.74% |
$8.49K - $13.9K
|
42.8K
$76.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-9.75K- 4.64% |
$20.2K - $33.2K
|
200K
$358K
|
|
|
Jan 16, 2024
Q4 2023
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-10K- 29.62% |
$20.7K - $34K
|
23.8K
$42.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-30.7K- 47.11% |
$63.6K - $104K
|
34.5K
$61.8K
|